Treating Patients with Type 2 Diabetes Mellitus Uncontrolled on Basal Insulin in the Czech Republic: Cost-Effectiveness of IDegLira Versus iGlarLixi
在捷克共和国，使用IDegLira治疗基础胰岛素治疗血糖控制不佳的2型糖尿病患者：IDegLira与iGlarLixi的成本效益分析
期刊:Diabetes Therapy
影响因子:2.6
doi:10.1007/s13300-019-0569-7
Pöhlmann, Johannes; Russel-Szymczyk, Monika; Holík, Pavel; Rychna, Karel; Hunt, Barnaby
